Baker McKenzie advised the shareholders of Biopharma on the carve-out of its non-plasma business and its further sale to Stada AG. Arzinger acted as a legal…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Paolo Bossi
…
This content is for Standard 1 Year members only. LoginJoin Now